High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma
Conclusion:
Elevated SII is an independent adverse prognostic factor in patients with resectable gastroesophageal adenocarcinomas with and without neoadjuvant treatment.
Source: Annals of Surgery - Category: Surgery Tags: ORIGINAL ARTICLES Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Esophagectomy | Esophagus Cancer | Gastroenterology | Neoadjuvant Therapy | Study | Surgery